| View |
|
|
|
|
| View |
Meformin hydrochloride + Gliclazide
|
500 mg/30 mg
|
Sustained - Release Tablet
|
|
| View |
Meformin hydrochloride + Gliclazide
|
500 mg/30 mg
|
Sustained - Release Tablet
|
|
| View |
Semaglutide
|
3 mg
|
Tablet
|
|
| View |
Semaglutide
|
7 mg
|
Tablet
|
|
| View |
Semaglutide
|
14 mg
|
Tablet
|
|
| View |
Semaglutide
|
1 mg
|
Solution for Injection in Pre-filled Pen
|
|
| View |
Gemigliptin (as tartrate sesquihydrate) + Metformin hydrochloride
|
50 mg/1g
|
Film-Coated tablet
|
|
| View |
Insulin Lispro
|
100 Units/mL (3.5 mg/mL)
(50% Insulin Lispro and 50% Insulin Lispro Protamine)
|
Suspension for Injection (SC)
|
|
| View |
Insulin Lispro (rDNA)
|
100 Units/mL (3.5 mg/mL) (25% Insulin Lispro Solution + 75% Insulin Lispro Protamine)
|
Suspension for Injection (SC)
|
22 March 2023
|
| View |
Metformin Hydrochloride
|
1 g
|
Prolonged-Release Tablet
|
22 March 2023
|
| View |
Pioglitazone (as Hydrochloride + Metformin Hydrochloride)
|
15 mg/500mg
|
Sustained-Release Tablet
|
22 March 2023
|
| View |
Pioglitazone (as Hydrochloride + Metformin Hydrochloride)
|
30 mg/500mg
|
Sustained-Release Tablet
|
22 March 2023
|
| View |
Dapagliflozin + Metformin Hydrochloride
|
5 mg/1g
|
Film-Coated Tablet
|
|
| View |
Dapagliflozin + Metformin Hydrochloride
|
5 mg/500 mg
|
Film-Coated Tablet
|
|
| View |
Dapagliflozin + Metformin Hydrochloride
|
5 mg/1g
|
Film-Coated Tablet
|
|
| View |
Dapagliflozin + Metformin Hydrochloride
|
5 mg/500 mg
|
Film-Coated Tablet
|
|
| View |
Dapagliflozin + Metformin Hydrochloride
|
10 mg/1g
|
Film-Coated Tablet
|
14 June 2023
|
| View |
Dapagliflozin + Metformin Hydrochloride
|
10 mg/500 mg
|
Film-Coated Tablet
|
14 June 2023
|
| View |
Dapagliflozin + Metformin Hydrochloride
|
5 mg/1g
|
Film-Coated Tablet
|
|